The transaction is awaiting CCI approval
Warburg Pincus has signed a definitive agreement to invest ~US$ 210 million for a minority stake in Micro Life Sciences, parent organisation of Meril group of companies.
The transaction is awaiting CCI approval.
Meril designs, manufactures and distributes medical devices and is making significant strides in capturing the global opportunity in both established product categories and market-defining innovations.
Sanjeev Bhatt, Sr. Vice President-Corporate Strategy, Meril said, “We are excited to partner with Warburg Pincus which has a rich history of working with several successful medical device companies globally. The current investment establishes high degree of credibility to Indian medical devices in the global landscape and will help us in deepening our international presence, attracting global talent, and scaling up our clinical research efforts in order to achieve our vision of improving the quality of human life through advanced healthcare solutions.”